
Loading, please wait...

Loading, please wait...

This pooled real-world analysis compared brivaracetam, cenobamate, lacosamide, and perampanel as adjunctive treatments in 1,949 adults with drug-resistant focal epilepsy from 71 epilepsy centers. Lacosamide accounted for 241 prescriptions. Cenobamate demonstrated significantly greater odds of achieving at least a 50% seizure reduction at 6 months compared with lacosamide, with similar advantages for seizure freedom and response at 12 months. However, lacosamide had the lowest incidence of adverse effects among the four treatments, occurring in 14.8% of patients, compared with 57.8% for cenobamate. Treatment retention at 12 months did not significantly differ between cenobamate and lacosamide. The findings therefore position lacosamide as an option with a comparatively favorable tolerability profile, although the study did not demonstrate superior seizure-control effectiveness compared with cenobamate.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This pooled real-world analysis compared brivaracetam, cenobamate, lacosamide, and perampanel as adjunctive treatments in 1,949 adults with drug-resistant focal epilepsy from 71 epilepsy centers. Lacosamide accounted for 241 prescriptions. Cenobamate demonstrated significantly greater odds of achieving at least a 50% seizure reduction at 6 months compared with lacosamide, with similar advantages for seizure freedom and response at 12 months. However, lacosamide had the lowest incidence of adverse effects among the four treatments, occurring in 14.8% of patients, compared with 57.8% for cenobamate. Treatment retention at 12 months did not significantly differ between cenobamate and lacosamide. The findings therefore position lacosamide as an option with a comparatively favorable tolerability profile, although the study did not demonstrate superior seizure-control effectiveness compared with cenobamate.
last month

Hospital-acquired anemia affects over 60% of intensive care patients, significantly prolonging ICU stays. Discover key drivers such as diagnostic phlebotomy and hemodilution, along with actionable patient blood management strategies to conserve hemoglobin and improve clinical outcomes.
Last week

Maternal anaemia contributes to nearly half of pregnancy-related fatalities across India. To prevent complications, Uttar Pradesh has added single-dose parenteral iron to its essential medicines list. This clinical transition aims to restore haemoglobin rapidly and protect high-risk mothers across rural facilities.
4 weeks back

India's food safety authority FSSAI has issued show-cause notices to Gemini Edibles, BigBasket, and Flipkart for unpermitted cardiovascular claims regarding Freedom Rice Bran Oil. This regulatory move highlights the strict enforcement of advertising standards and the clinical necessity of evidence-based lipid care.
3 weeks back

The state government is deploying helicopter emergency medical services across the Mumbai-Pune Expressway, Samruddhi Mahamarg, and Mumbai-Goa Highway. This initiative establishes unified standard operating procedures to enable rapid triage, advanced prehospital resuscitation, and seamless trauma care transfers.
4 weeks back

Atherosclerotic cardiovascular disease guidelines often rely on European-derived lipoprotein(a) cutoffs. However, baseline Lp(a) levels vary widely across ancestries, including South Asians and Africans. Clinicians must interpret Lp(a) values within overall absolute cardiovascular risk.
4 weeks back